Hap Trading, LLC Clene Inc. Transaction History
Hap Trading, LLC
- $840 Billion
- Q2 2024
A detailed history of Hap Trading, LLC transactions in Clene Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 16,900 shares of CLNN stock, worth $89,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,900Holding current value
$89,570% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CLNN
# of Institutions
47Shares Held
6.9MCall Options Held
287KPut Options Held
162K-
Vanguard Group Inc Valley Forge, PA2.62MShares$13.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA922KShares$4.88 Million0.0% of portfolio
-
Lunt Capital Management, Inc. Holladay, UT591KShares$3.13 Million0.1% of portfolio
-
Scoggin Management LP New York, NY375KShares$1.99 Million0.05% of portfolio
-
Morgan Stanley New York, NY339KShares$1.79 Million0.0% of portfolio
About Clene Inc.
- Ticker CLNN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,502,000
- Market Cap $337M
- Description
- Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...